159 related articles for article (PubMed ID: 10028188)
1. Why is the ANA result positive?
Illei GG; Klippel JH
Bull Rheum Dis; 1999 Jan; 48(1):1-4. PubMed ID: 10028188
[TBL] [Abstract][Full Text] [Related]
2. Antinuclear antibody testing. A study of clinical utility.
Slater CA; Davis RB; Shmerling RH
Arch Intern Med; 1996 Jul; 156(13):1421-5. PubMed ID: 8678710
[TBL] [Abstract][Full Text] [Related]
3. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases.
Salonen EM; Miettinen A; Walle TK; Koskenmies S; Kere J; Julkunen H
Ann Rheum Dis; 2004 Oct; 63(10):1250-4. PubMed ID: 15361381
[TBL] [Abstract][Full Text] [Related]
4. The antinuclear antibody test. When is a positive result clinically relevant?
Thomas C; Robinson JA
Postgrad Med; 1993 Aug; 94(2):55-8, 63, 66. PubMed ID: 8341626
[TBL] [Abstract][Full Text] [Related]
5. Arthralgias, myalgias, facial erythema, and a positive ANA: not necessarily SLE.
Alarcón GS
Cleve Clin J Med; 1997; 64(7):361-4. PubMed ID: 9223765
[No Abstract] [Full Text] [Related]
6. [Clinical utility of serum diagnostic tests for rheumatic diseases].
Mindlin A
Rev Med Brux; 2007 Sep; 28(4):302-7. PubMed ID: 17958025
[TBL] [Abstract][Full Text] [Related]
7. Abnormal antinuclear antibody titers are less common than generally assumed in established cases of systemic lupus erythematosus.
Sjöwall C; Sturm M; Dahle C; Bengtsson AA; Jönsen A; Sturfelt G; Skogh T
J Rheumatol; 2008 Oct; 35(10):1994-2000. PubMed ID: 18785312
[TBL] [Abstract][Full Text] [Related]
8. Measurement of serum antinuclear antibody titer in dogs with and without systemic lupus erythematosus: 120 cases (1997-2005).
Smee NM; Harkin KR; Wilkerson MJ
J Am Vet Med Assoc; 2007 Apr; 230(8):1180-3. PubMed ID: 17501657
[TBL] [Abstract][Full Text] [Related]
9. Clinical utility of screening for antinuclear antibodies by enzyme immunoassay--a preliminary study.
Divate S; Hardikar P; Bichile LS; Rajadhyaksha A
J Assoc Physicians India; 2004 Apr; 52():290-3. PubMed ID: 15636329
[TBL] [Abstract][Full Text] [Related]
10. The clinical utility of a positive antinuclear antibody test result.
Abeles AM; Abeles M
Am J Med; 2013 Apr; 126(4):342-8. PubMed ID: 23395534
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic and prognostic significance of different antinuclear antibodies in more than 1000 consecutive Albanian patients with rheumatic diseases.
Sulcebe G; Morcka K
Clin Exp Rheumatol; 1992; 10(3):255-61. PubMed ID: 1582070
[TBL] [Abstract][Full Text] [Related]
12. Information on diagnosis and management of systemic lupus erythematosus derived from the routine measurement of 8 nuclear autoantibodies.
Ignat GP; Rat AC; Sychra JJ; Vo J; Varga J; Teodorescu M
J Rheumatol; 2003 Aug; 30(8):1761-9. PubMed ID: 12913932
[TBL] [Abstract][Full Text] [Related]
13. [Diagnostic significance of antinuclear antibodies].
Swaak AJ
Ned Tijdschr Geneeskd; 2000 Mar; 144(13):585-9. PubMed ID: 10761543
[TBL] [Abstract][Full Text] [Related]
14. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K
Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207
[TBL] [Abstract][Full Text] [Related]
15. Methods of choice for diagnostic antinuclear antibody (ANA) screening: benefit of adding antigen-specific assays to immunofluorescence microscopy.
Dahle C; Skogh T; Aberg AK; Jalal A; Olcén P
J Autoimmun; 2004 May; 22(3):241-8. PubMed ID: 15041045
[TBL] [Abstract][Full Text] [Related]
16. Clinical utility of common serum rheumatologic tests.
Lane SK; Gravel JW
Am Fam Physician; 2002 Mar; 65(6):1073-80. PubMed ID: 11925083
[TBL] [Abstract][Full Text] [Related]
17. Autoantibody determination in the diagnosis of systemic lupus erythematosus.
Kurien BT; Scofield RH
Scand J Immunol; 2006 Sep; 64(3):227-35. PubMed ID: 16918691
[TBL] [Abstract][Full Text] [Related]
18. Anti-nucleosome antibodies in patients with systemic lupus erythematosus of recent onset. Potential utility as a diagnostic tool and disease activity marker.
Simón JA; Cabiedes J; Ortiz E; Alcocer-Varela J; Sánchez-Guerrero J
Rheumatology (Oxford); 2004 Feb; 43(2):220-4. PubMed ID: 13130152
[TBL] [Abstract][Full Text] [Related]
19. ANAs and antibodies to DNA: their use in clinical diagnosis.
Reichlin M
Bull Rheum Dis; 1993 Nov; 42(7):3-5. PubMed ID: 8173647
[TBL] [Abstract][Full Text] [Related]
20. Critical appraisal of the pattern of antinuclear antibodies (ANA) testing requested over a six month period at the "Escola Paulista de Medicina" (EPM), São Paulo.
Quaresma MR; Krauthamer A; Ferraz MB; Leser PG; Atra E
Rev Paul Med; 1993; 111(3):391-6. PubMed ID: 8108631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]